Neurogene (NGNE) Interest & Investment Income (2013 - 2026)

Neurogene has reported Interest & Investment Income for 12 years, with the latest figure at $2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Interest & Investment Income fell 29.48% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $10.6 million (up 13.34% YoY), and the FY2025 full-year result was $11.5 million, up 36.38% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $2.3 million, down from $2.7 million in the prior quarter.
• The five-year high for Interest & Investment Income was $3.2 million in Q1 2025, with the low at $650000.0 in Q3 2023.
• Historically, Interest & Investment Income has averaged $1.9 million across 4 years, with a median of $2.3 million in 2026.
• Annual changes were most pronounced in 2024 — Interest & Investment Income jumped 198.58% — and 2026, when it decreased 29.48%.
• Neurogene's Interest & Investment Income stood at $781000.0 in 2023, then soared by 190.65% to $2.3 million in 2024, then advanced by 17.75% to $2.7 million in 2025, then dropped by 15.41% to $2.3 million in 2026.
• The last three Interest & Investment Income figures came in at $2.3 million (Q1 2026), $2.7 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.